-
-
-
-
-
-
-
NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commercialization of NLG207
-
-
-
-
-
-
-
Evercel, Inc. (EVRC) Announces Rejected Offer to Acquire NewLink Genetics (NLNK)
-
-
-
-
-
-
-
NewLink Genetics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NewLink Genetics Provides Corporate Update and Reports Second Quarter 2019 Financial Results
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/04: (CTMX) (CATB) (MYL) Higher; (CLSN) (MNTA) (TEVA) (ODP) Lower (more...)
-
-
-
-
-
-
-
Notable 52-Week Highs and Lows 5/10: (MGT) (AMZN) (BERY) High; (GPS) (NLNK) (ZBRA) Low
-
-
-
-
-
-
-
Market Wrap: Defense Sec. Hagel Steps Down; Abrupt Departure for UTC CEO; Merck Acquires Ebola Vaccine Rights
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

